Seán Sherlock (Cork East, Labour)
Link to this: Individually | In context | Oireachtas source

881. To ask the Minister for Health his views on the clinical effectiveness of the drug respreeza; and if he will now include respreeza for reimbursement. [19504/17]

Mattie McGrath (Tipperary, Independent)
Link to this: Individually | In context | Oireachtas source

963. To ask the Minister for Health if he will review all the evidence in relation to alpha-1 respreeza and enter into meaningful discussions with a company (details supplied) to find a solution to make respreeza available for persons as soon as possible; and if he will make a statement on the matter. [19850/17]

Mattie McGrath (Tipperary, Independent)
Link to this: Individually | In context | Oireachtas source

964. To ask the Minister for Health if he will engage with a company (details supplied) with a view to lifting the 31 May 2017 deadline for providing alpha-1 respreeeza therapy to the 21 persons currently on respreeza in order to allow discussions take place in a favourable environment; and if he will make a statement on the matter. [19851/17]

Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source

I propose to take Questions Nos. 881, 963 and 964 together.

Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.